Top Markets
Coin of the day
Pathfinder Cell Therapy, Inc. Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy, Inc.

PFND
Rang in Aktien #40886
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in... Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$66.72K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Pathfinder Cell Therapy, Inc. (PFND)

Kategorie

Kursverlauf für Pathfinder Cell Therapy, Inc. (PFND)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $0.49 am 2000-01-01
Kursverlauf der Aktie von Pathfinder Cell Therapy, Inc. von 2000 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -4.50%
2024 0.00%
2023 27.27%
2022 -21.43%
2021 -95.62%
2020 44.91%
2019 23.24%
2018 -41.02%
2017 143.39%
2016 -79.44%
2015 257.08%
2014 -89.60%
2013 -35.40%
2012 -66.73%
2011 -4.69%
2010 -66.98%
2009 27.22%
2008 -77.57%
2007 -36.62%
2006 131.85%
2005 9.98%
2004 12.34%
2003 164.05%
2002 -29.11%
2001 101.01%
2000 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$522.59 31.99%
US
$863.65 33.57%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE